Dr. Solforosi is currently a Senior Scientist at Janssen Infectious Disease Vaccine in Leiden, The Netherlands. She has extensive experiences in academic as well as industry research. Her background is in microbiology, molecular biology and immunology including antibody generation and vaccine development. She has led and contributed to projects for the development and characterization of pathogens’ tumor specific antibodies and characterization of B cell response following vaccination. She received her Ph.D. from the University of Padova, Italy, and performed her postdoctoral work in Dr. Burton laboratory at the Scripps Research Institute (TSRI), in La Jolla California, recognized as the leading laboratory for anti-HIV antibodies generation and HIV vaccine development. Dr. Solforosi continued her work at TSRI as an Assistant Professor and also worked as senior scientist at the Tyrolean Cancer Research Institute, Innsbruck, Austria, and at the University Vita-Salute San Raffaele, Milan, Italy.

  Dr. Solforosi is currently a Senior Scientist at Janssen Infectious Disease Vaccine in Leiden, The Netherlands. She has extensive experiences in academic as well as industry research. Her background is in microbiology, molecular biology and immunology including antibody generation and vaccine development. She has led and contributed to projects for the development and characterization of pathogens’ tumor specific antibodies and characterization of B cell response following vaccination. She received her Ph.D. from the University of Padova, Italy, and performed her postdoctoral work in Dr. Burton laboratory at the Scripps Research Institute (TSRI), in La Jolla California, recognized as the leading laboratory for anti-HIV antibodies generation and HIV vaccine development. Dr. Solforosi continued her work at TSRI as an Assistant Professor and also worked as senior scientist at the Tyrolean Cancer Research Institute, Innsbruck, Austria, and at the University Vita-Salute San Raffaele, Milan, Italy.